C. Taggart (Belfast, United Kingdom), R. A. Stockley (Birmingham, United Kingdom)
Dimethylfumarate reduces growth factor- and cytokine-induced IL-6 release from human lung fibroblasts: role of (NF)-κB
P. Seidel, I. Merfort, M. Gencay, M. Hughes, M. Tamm, M. Roth (Basel, Switzerland; Freiburg, Germany; Sydney, Australia)
|  |
Co-expression of p21Waf1/Cip1 improves adenoviral vector-mediated transgene expression
A. Schumacher, S. Horvat, C. Woischwill, C. Witt (Berlin, Germany)
| |
Influence of tumour cell lysate on state of lymphocytes‘ activation after DCs stimulation in lung cancer
O. Jankowska, P. Krawczyk, D. Sagan, K. Wojas-Krawczyk, J. Milanowski, K. Gozdziuk (Lublin, Poland)
| |
The effects of erdosteine and N-acetylcysteine treatment following lung injury on the regulation of apoptosis of capillary endothelial cells in the model of experimental pulmonary fibrosis induced by bleomycin
R. Demiralay, N. Gürsan, M. Çalik (Isparta, Erzurum, Turkey)
| |
Pulmonary capillary hemangiomatosis (PCH): immunohistochemical analysis of vascular endothelial growth factor and its receptors
A. Krill, H. Wilkens, G. W. Sybrecht, R. M. Bohle (Homburg/Saar, Germany)
| |
Functional expression of TLR9 on BAL clls from sarcoidosis patients
J. Yalcintepe, K. Schubert, A. Prasse, J. Müller-Quernheim, G. Zissel (Freiburg, Germany)
|  |
Role of arginase and NOS2 in the regulation of CCL18 release
X. Fan, K. Höhne, A. Prasse, J. Müller-Quernheim, G. Zissel (Freiburg, Germany)
| |
Upregulated expression and release of VEGF from human airway smooth muscle cells in relation to fibroblast growth factors
B. Vanoudenaerde, A. Willems-Widyastuti, R. Vos, W. de Boer, H. Sharma, G. Verleden (Rotterdam, Leiden, Netherlands; Leuven, Belgium)
| |
Inhibition of IgE-induced airway smooth muscle cell constriction by the anti-IgE-antibody omalizumab
M. Roth, M. Tamm (Basel, Switzerland)
| |
TNF-α-induced CD38 expression in human airway smooth muscle cells: role of PI3K/Akt pathway
K. Tirumurugaan, J. Jude, B. N. Kang, T. Walseth, M. Kannan (Saint Paul, MN, Minneapolis, MN, United States Of America)
| |
Microsatellite alterations in cell-free body fluids for the discrimination of lung cancer patients from patients with benign lung diseases
T. Kulbaka, S. Weickmann, C. Witt, M. Fleischhacker, B. Schmidt (Berlin, Germany)
| |
Comparative proteomics of human bronchoalveolar lavage fluid from COPD and non-COPD subjects
D. M. Desiderio, F. Giorgianni, S. Beranova-Giorgianni, V. Mileo, L. Chen, S. Catinella (Memphis, TN, United States Of America; Parma, Italy)
| |
Cytokine pattern in the exhaled breath of patients with planocellular lung carcinomas
I. Barta, T. Kullmann, I. Horváth, B. Antus (Budapest, Hungary)
| |
Experimental target therapy in mesothelioma cells
H. Popper, H. Kothmaier, I. Halbwedl (Graz, Austria)
| |